EP2330124

Hybrid polypeptides with selectable properties

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    11.8.2006
  • EP published:
    25.2.2015
  • EP application number:
    10012149.0
  • Max expiry date:
    10.8.2026
  • Title:
    Hybrid polypeptides with selectable properties

Timeline

Today
11.8.2006EP application
25.2.2015EP Publication

Owner

  • Name:
    Amylin Pharmaceuticals, LLC
  • Address:
    9360 Towne Centre Drive, 92121, San Diego, CA, US
  • Name:
    AstraZeneca Pharmaceuticals LP
  • Address:
    1800 Concord Pike, Wilmington, DE, US

Inventor

  • Name:
    Levy, Odile Esther
  • Address:
    San Diego, CA, US
  • Name:
    Hanley, Michael R.
  • Address:
    San Diego, CA, US
  • Name:
    Jodka, Carolyn M.
  • Address:
    San Diego, CA, US
  • Name:
    Lewis, Diana
  • Address:
    San Diego, CA, US
  • Name:
    Soares, Christopher J.
  • Address:
    San Diego, CA, US
  • Name:
    Ghosh, Soumitra S.
  • Address:
    San Diego, CA, US
  • Name:
    D'Souza, Lawrence
  • Address:
    San Diego, CA, US
  • Name:
    Parkes, David G.
  • Address:
    San Diego, CA, US
  • Name:
    Mack, Christine M.
  • Address:
    San Diego, CA, US
  • Name:
    Forood, Behrouz Bruce
  • Address:
    San Diego, CA, US

Priority

  • Number:
    201664
  • Date:
    11.8.2005
  • Country:
    US
  • Number:
    206903
  • Date:
    17.8.2005
  • Country:
    US
  • Number:
    301744
  • Date:
    12.12.2005
  • Country:
    US

Classification

  • Categories:
    C07K 14/575, A61K 38/00

Upload documents